Petri Bono

Member of the Scientific Advisory Board at TILT Biotherapeutics

Petri Bono is Director of the Cancer Center at Helsinki University Central Hospital, the only OECI approved Comprehensive Cancer Center in Northern Europe. There are over 100 MDs and more than 16.000 patient visits to the Center every year making it one of the largest cancer centers in Europe. Dr Bono’s own research has involved many areas of molecular and immunological oncology. As he did his PhD in basic and applied immunology, he is uniquely suited to drive immune-oncology forward clinically. Dr Bono has participated in numerous clinical trials including early phase immuno-oncological trials and published 60 peer reviewed papers in international journals.

Timeline

  • Member of the Scientific Advisory Board

    Current role